Roche Palo patent expiration
1. Cellcept patent expiration
| Drug Patent Number | Company | Drug Patent Title | Drug Patent Expiry | Activity Alert |
|---|---|---|---|---|
| These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc). | ||||
| US5543408 | ROCHE PALO | Crystalline anhydrous mycophenolate mofetil and intravenous formulation thereof |
Sep, 2013
(10 years ago) | |
Drugs and Companies using MYCOPHENOLATE MOFETIL HYDROCHLORIDE ingredient
Market Authorisation Date: 12 August, 1998
Treatment: NA
Dosage: INJECTABLE
More Information on Dosage
CELLCEPT family patents
2. Cellcept patent expiration
| Drug Patent Number | Company | Drug Patent Title | Drug Patent Expiry | Activity Alert |
|---|---|---|---|---|
| These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc). | ||||
| US5688529 | ROCHE PALO | Mycophenolate mofetil high dose oral suspensions |
Nov, 2014
(9 years ago) | |
Drugs and Companies using MYCOPHENOLATE MOFETIL ingredient
Market Authorisation Date: 01 October, 1998
Treatment: NA
Dosage: FOR SUSPENSION
How can I launch a generic of CELLCEPT before it's drug patent expiration?
More Information on Dosage
CELLCEPT family patents